135 related articles for article (PubMed ID: 34341212)
21. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias.
Liang R; Chan VV; Chan TK; Chiu E; Todd D
Acta Haematol; 1991; 85(2):71-5. PubMed ID: 1850943
[TBL] [Abstract][Full Text] [Related]
22. Ponatinib: a review of its use in adults with chronic myeloid leukaemia or Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Hoy SM
Drugs; 2014 May; 74(7):793-806. PubMed ID: 24807266
[TBL] [Abstract][Full Text] [Related]
23. Marrow aplasia developing 3 years after treatment with busulphan for chronic myeloid leukaemia.
Bowcock SJ; Galton DA; Goldman JM
Eur J Haematol; 1989 May; 42(5):496-7. PubMed ID: 2567249
[TBL] [Abstract][Full Text] [Related]
24. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
Shimon I; Kneller A; Olchovsky D
Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
[TBL] [Abstract][Full Text] [Related]
25. Combined chronic myeloid leukaemia and chronic lymphocytic leukaemia in five patients, including one with 17p deletion.
Armarego M; Gottlieb D; Dunlop L; Cooney JP
Intern Med J; 2021 Apr; 51(4):580-584. PubMed ID: 33890366
[TBL] [Abstract][Full Text] [Related]
26. Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms.
Choi DC; Tremblay D; Iancu-Rubin C; Mascarenhas J
Ann Hematol; 2017 Jun; 96(6):919-927. PubMed ID: 28062906
[TBL] [Abstract][Full Text] [Related]
27. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
[TBL] [Abstract][Full Text] [Related]
28. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
29. Current and emerging tests for the laboratory monitoring of chronic myeloid leukaemia and related disorders.
Ross DM; Hughes TP
Pathology; 2008 Apr; 40(3):231-46. PubMed ID: 18428043
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.
Aggerholm A; Grønbaek K; Guldberg P; Hokland P
Eur J Haematol; 2000 Aug; 65(2):109-13. PubMed ID: 10966170
[TBL] [Abstract][Full Text] [Related]
31. [An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia].
Polosukhina ER; Kuznetsov SV; Logcheva NP; Zabotina TN; Tenuta MR; Shirin AD; Kaletin GI; Turkina AG; Tsvetaeva NV; Shishkin IuV; Kadagidze ZG; Khoroshko ND; Volkova MA; Baryshnikov AIu
Ter Arkh; 1998; 70(7):21-5. PubMed ID: 9742630
[TBL] [Abstract][Full Text] [Related]
32. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
33. Topotecan-based combination chemotherapy in patients with transformed chronic myelogenous leukemia and advanced myelodysplastic syndrome.
Park SJ; Kim DW; Kim HJ; Eom HS; Min CK; Lee JW; Min WS; Kim CC
Korean J Intern Med; 2000 Jul; 15(2):122-6. PubMed ID: 10992724
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
35. Ponatinib in childhood Philadelphia chromosome-positive leukaemias: an international registry of childhood chronic myeloid leukaemia study.
Millot F; Suttorp M; Versluys AB; Kalwak K; Nelken B; Ducassou S; Bertrand Y; Baruchel A
Eur J Cancer; 2020 Sep; 136():107-112. PubMed ID: 32668374
[TBL] [Abstract][Full Text] [Related]
36. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
Melo JV; Goldman JM
Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
[TBL] [Abstract][Full Text] [Related]
37. TGFα expression in myeloid malignancies.
Kavanagh S; Mirzai B; Fuller K; Erber WN
J Clin Pathol; 2016 Jun; 69(6):543-6. PubMed ID: 26984929
[TBL] [Abstract][Full Text] [Related]
38. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome?
Oscier DG
Br J Haematol; 1996 Mar; 92(3):582-6. PubMed ID: 8616021
[TBL] [Abstract][Full Text] [Related]
39. How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.
Hehlmann R; Lauseker M
Leukemia; 2024 Feb; 38(2):465-466. PubMed ID: 38218735
[No Abstract] [Full Text] [Related]
40. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]